Zhou, Ting http://orcid.org/0000-0001-8783-8380
Damsky, William
Weizman, Orr-El
McGeary, Meaghan K. http://orcid.org/0000-0002-8505-7158
Hartmann, K. Patricia
Rosen, Connor E. http://orcid.org/0000-0003-2442-3676
Fischer, Suzanne
Jackson, Ruaidhri
Flavell, Richard A. http://orcid.org/0000-0003-4461-0778
Wang, Jun
Sanmamed, Miguel F.
Bosenberg, Marcus W.
Ring, Aaron M. http://orcid.org/0000-0003-3699-2446
Article History
Received: 30 July 2019
Accepted: 2 April 2020
First Online: 24 June 2020
Competing interests
: A.M.R., T.Z., and S.F. are named inventors on a patent application that describes the DR-18 molecule. A.M.R. is the founder of Simcha Therapeutics, the commercial licensee of DR-18, and holds equity in the immuno-oncology companies Forty-Seven Inc., ALX Oncology, and Medicenna Therapeutics. W.D. and M.W.B. serve as consultants for Eli Lilly. W.D. has research funding from Pfizer for unrelated work.